Feng Gao Selected Research

acetyl ferulaic isosorbide

3/2009

[Synthesis and cardioprotective effect of a novel anti-ischemic/reperfused injury compound].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Feng Gao Research Topics

Disease

396	Neoplasms (Cancer) 10/2022 - 02/2002
133	Infections 06/2022 - 04/2003
92	Inflammation (Inflammations) 05/2022 - 07/2002
72	Breast Neoplasms (Breast Cancer) 06/2022 - 02/2002
62	Reperfusion Injury 10/2022 - 05/2002
59	Ischemia 01/2021 - 02/2002
55	Neoplasm Metastasis (Metastasis) 11/2022 - 09/2003
51	Colorectal Neoplasms (Colorectal Cancer) 08/2022 - 05/2005
36	Insulin Resistance 01/2022 - 03/2008
36	Leukemia 11/2021 - 06/2002
35	Hypoxia (Hypoxemia) 08/2022 - 01/2005
34	Stroke (Strokes) 03/2022 - 05/2010
33	Myocardial Ischemia (Ischemic Heart Diseases) 10/2022 - 03/2002
33	Myocardial Infarction 06/2022 - 02/2002
32	Hemorrhage 01/2022 - 01/2006
30	Fibrosis (Cirrhosis) 06/2022 - 11/2011
30	Carcinogenesis 04/2021 - 10/2005
27	Wounds and Injuries (Trauma) 12/2022 - 06/2005
27	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 04/2010
27	Ischemic Stroke 09/2022 - 04/2011
27	Pancreatic Neoplasms (Pancreatic Cancer) 07/2022 - 06/2008
26	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 08/2002
25	Pain (Aches) 06/2022 - 01/2005
24	Atherosclerosis 05/2022 - 01/2002
24	Necrosis 01/2022 - 03/2003
23	Carcinoma (Carcinomatosis) 03/2022 - 01/2005
22	Body Weight (Weight, Body) 03/2022 - 07/2002
22	Infarction (Infarctions) 02/2022 - 09/2005
22	Pathologic Constriction (Stenosis) 01/2022 - 10/2009
22	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 08/2004
21	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 01/2002
21	Type 2 Diabetes Mellitus (MODY) 01/2022 - 08/2006
20	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2011
19	Hypertension (High Blood Pressure) 01/2022 - 08/2006
18	Colonic Neoplasms (Colon Cancer) 01/2022 - 12/2010
18	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2006
17	Heart Failure 01/2022 - 03/2007
15	Spinal Cord Injuries (Spinal Cord Injury) 12/2022 - 11/2012
15	Glioma (Gliomas) 10/2022 - 04/2013
15	Disease Progression 01/2021 - 09/2002
14	Stomach Neoplasms (Stomach Cancer) 01/2022 - 11/2003
14	Melanoma (Melanoma, Malignant) 01/2022 - 07/2005
14	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 04/2011
13	Triple Negative Breast Neoplasms 01/2022 - 09/2010
13	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 11/2009
13	Hyperglycemia 01/2022 - 09/2007
13	Adenocarcinoma 01/2022 - 08/2008
13	Thrombosis (Thrombus) 10/2021 - 07/2008
12	Myasthenia Gravis 01/2022 - 11/2008
12	Cognitive Dysfunction 01/2022 - 02/2016

Drug/Important Bio-Agent (IBA)

153	Proteins (Proteins, Gene)FDA Link 12/2022 - 09/2002
80	Biomarkers (Surrogate Marker)IBA 11/2022 - 09/2008
80	Pharmaceutical PreparationsIBA 10/2022 - 05/2003
55	Insulin (Novolin)FDA Link 01/2022 - 03/2002
48	Messenger RNA (mRNA)IBA 12/2022 - 05/2002
44	Biological ProductsIBA 01/2022 - 01/2002
38	MicroRNAs (MicroRNA)IBA 11/2022 - 09/2012
38	Peptides (Polypeptides)IBA 01/2022 - 09/2002
37	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 03/2003
37	CytokinesIBA 01/2022 - 09/2002
32	VaccinesIBA 01/2022 - 03/2005
32	AntibodiesIBA 10/2021 - 08/2002
31	EnzymesIBA 01/2022 - 11/2003
30	Therapeutic UsesIBA 06/2022 - 06/2002
28	AntigensIBA 01/2022 - 04/2003
26	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 03/2003
25	Long Noncoding RNAIBA 10/2022 - 10/2016
23	Hyaluronic Acid (Hyaluronan)IBA 01/2022 - 09/2003
22	Small Interfering RNA (siRNA)IBA 02/2022 - 10/2009
21	RNA (Ribonucleic Acid)IBA 07/2022 - 04/2003
21	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 02/2008
20	Interleukin-6 (Interleukin 6)IBA 01/2022 - 09/2002
19	Antiviral Agents (Antivirals)IBA 06/2022 - 09/2010
19	Paclitaxel (Taxol)FDA LinkGeneric 06/2022 - 02/2009
19	Anti-Bacterial Agents (Antibiotics)IBA 04/2022 - 07/2007
19	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 10/2006
19	Caspase 3 (Caspase-3)IBA 01/2022 - 09/2003
17	LipidsIBA 04/2022 - 06/2006
17	CollagenIBA 04/2022 - 02/2005
17	Phosphotransferases (Kinase)IBA 01/2022 - 02/2006
17	AntioxidantsIBA 12/2021 - 05/2002
16	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2022 - 07/2002
15	EpitopesIBA 03/2022 - 03/2005
15	Indicators and Reagents (Reagents)IBA 01/2022 - 08/2005
15	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 06/2008
14	InterleukinsIBA 10/2021 - 10/2010
13	Estrogen ReceptorsIBA 01/2022 - 10/2009
13	Neutralizing AntibodiesIBA 01/2022 - 04/2003
13	Daunorubicin (Cerubidine)FDA LinkGeneric 02/2011 - 04/2006
12	ErbB Receptors (EGF Receptor)IBA 10/2022 - 02/2006
12	Broadly Neutralizing AntibodiesIBA 01/2022 - 09/2011

Therapy/Procedure

206	Therapeutics 08/2022 - 08/2002
58	Drug Therapy (Chemotherapy) 03/2022 - 06/2003
28	Liver Transplantation 01/2020 - 10/2002
26	Stents 02/2022 - 03/2003
19	Thrombectomy 09/2022 - 06/2015
18	Radiotherapy 01/2022 - 01/2005
17	Immunotherapy 06/2022 - 02/2007
17	Transplantation 01/2022 - 04/2003
14	Lasers (Laser) 08/2022 - 06/2007